Skip to main content
INOVIQ LTD logo

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2016-06-27 Director's Dealing
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
Appendix 3Y - Gunzburg 2 pages 259.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change (on-market trades), and other related information. This type of document is a formal notification of personal share transactions by a company director. It is not a financial report, earnings release, or management discussion. The document length is 4018 characters, which is consistent with a detailed director's dealing notice. Therefore, the document fits the category of Director's Dealing (DIRS).
2016-06-27 English
Appendix 3Y - Gunzburg 2 pages 259.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number of shares acquired and held, nature of interest, and dates. This matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is 3679 characters, which is consistent with a detailed notice rather than a full financial report. There is no indication of financial statements, earnings data, or other report types. Therefore, the document is best classified as a Director's Dealing (DIRS) filing.
2016-06-20 English
Becoming a substantial holder 3 pages 140.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 filed under the Corporations Act 2001 Section 671B, titled 'Notice of initial substantial holder.' It details the substantial shareholding of Dr. Irmgard Irminger-Finger in Bard1 Life Sciences Limited, including voting power, relevant interests, and acquisition details. This type of filing is a notification of a major shareholding, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of share ownership crossing a threshold.
2016-06-19 English
Appendix 3Y - Gunzburg 2 pages 259.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in shareholding, including the number of shares acquired, disposed, and held after the change. The content focuses on personal share transactions by a company director. There is no financial performance data, earnings information, or report publication. The document fits the definition of 'Director's Dealing' which reports personal share transactions by company directors and executives (insider trades). The document length is 3628 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS with high confidence.
2016-06-19 English
Reinstatement to Official Quotation - 20 June 2016 1
Regulatory Filings Classification · 95% confidence The document is a market release announcing the reinstatement of the company's securities to official quotation on the stock exchange. It references compliance with listing rules and provides details about the shares and security code. There is no financial data, report content, or detailed analysis present. The document is an official announcement related to listing status, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like capital changes or delisting.
2016-06-16 English
ASX Notice 2 pages 282.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX notice regarding the reinstatement to official quotation of BARD1 Life Sciences Limited's securities after suspension. It includes details about the securities, trading information, escrowed shares, and references the company's Replacement Prospectus for further details. The document is a regulatory announcement about the status of the company's stock listing rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document length is short (2401 characters) and is clearly an official notice from the exchange about the reinstatement of trading. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance notices that do not fit other specific categories.
2016-06-16 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.